FDA Warns Hologic Over BioZorb Manufacturing Violations
The Food and Drug Administration issued a warning letter to Hologic Inc. HOLX, citing violations in the manufacturing and reporting processes for its BioZorb product line. The letter, addressed to CEO and President Stephen MacMillan, outlines significant …